PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME
足细胞内质网应激与肾病综合征
基本信息
- 批准号:9238166
- 负责人:
- 金额:$ 30.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAccountingApoptosisApoptoticAstrocytesAttenuatedCell Surface ReceptorsCessation of lifeComputer SimulationCoupledDNA Sequence AlterationDevelopmentDiagnosisEnd stage renal failureEndoplasmic ReticulumEngineeringFunctional disorderGenesGeneticGenetic ModelsGenetic VariationGoalsHumanInduced MutationInjuryKidneyKidney DiseasesKidney FailureKnock-outKnockout MiceLamininLeadLifeLinkMediatingMissense MutationMolecularMolecular TargetMorbidity - disease rateMusMutateMutationNephrotic SyndromePathogenesisPathogenicityPathway interactionsPatientsProteinsProteinuriaProto-Oncogene Proteins c-aktRegulationRenal functionResearchResearch PersonnelRiskRisk AssessmentRoleSignal TransductionSignaling ProteinTestingTherapeuticTimeTranscriptional RegulationTransgenic MiceTranslational ResearchUncertaintyUniversitiesVariantWashingtonbasecohortcostdisease phenotypedisorder riskeffective therapyendoplasmic reticulum stressgenetic variantglomerular basement membranehigh throughput screeningin vivoinnovationknock-downlamin B2mortalitymouse modelmutantneurotrophic factornext generation sequencingnovelnovel therapeutic interventionnovel therapeuticsoverexpressionpodocyteresponsetooltranscription factor CHOPtreatment strategyvariant of unknown significance
项目摘要
Abstract
Nephrotic syndrome (NS) is characterized by heavy proteinuria and increased risk of loss of kidney
function. It causes serious morbidity and high mortality, accounting for 15% of prevalent end-stage renal
disease at an annual cost of more than $3 billion in the US. There is no effective treatment for most cases of
NS caused by genetic mutations. Our research has been focused on a monogenic form of NS caused by a
missense mutation (C321R) of LAMB2, one of the most commonly mutated genes in NS. Laminin 2 encoded
by LAMB2 is a component of laminin-521 ( 5 2 1), the major laminin trimer of the glomerular basement
membrane (GBM). Using our established knockout/transgenic mouse model, we have found that podocyte
endoplasmic reticulum (ER) stress and subsequent defective secretion of misfolded C321R-LAMB2 from
podocytes to the GBM lead to proteinuria. Furthermore, we have recently discovered an ER soluble factor that
promotes the survival of ER-stressed podocytes.
The overall goals of this proposal are to delineate molecular mechanisms regulating important death and
survival pathways activated by the C321R-LAMB2 mutation-induced podocyte ER stress, to determine the
contribution of podocyte ER stress in NS patients carrying putative deleterious missense variants, and to
investigate novel treatment strategies for genetic forms of NS. To accomplish our research goals, we will utilize
mouse genetic models and access two major human NS cohorts, Nephrotic Syndrome Study Network
(NEPTUNE) and the Washington University Kidney Translational Research Core (WU KTRC). We have
assembled an interdisciplinary team including multiple co-investigators and collaborators with the required
expertise in pioneering ER stress research, human and mouse genetics, next generation sequencing, and high
throughput screening.
The proposed study will help us classify NS patients based on underlying molecular mechanisms, stratify
disease risk, and discover highly-targeted treatments for NS patients caused by podocyte ER dysfunction.
摘要
肾病综合征(NS)的特征是大量蛋白尿和肾功能丧失的风险增加。
功能。本病发病率高,死亡率高,占终末期肾脏疾病的15%。
疾病,在美国每年的成本超过30亿美元。大多数病例都没有有效的治疗方法。
由基因突变引起的NS。我们的研究一直集中在一种单基因形式的NS上,这种形式由一种
LAMB2错义突变(C321R)是NS中最常见的突变基因之一。层粘连蛋白2编码
LAMB2是肾小球基底层粘连蛋白-521(521)的一个组成部分,是肾小球基底层粘连蛋白的主要三聚体
膜(GBM)。使用我们建立的基因敲除/转基因小鼠模型,我们发现足细胞
内质网应激与错折叠的C321R-LAMB2分泌缺陷
足细胞进入基底膜导致蛋白尿。此外,我们最近发现了一种内质网可溶性因子,
促进内质网应激足细胞的存活。
这项提案的总体目标是描绘调节重要死亡和
C321R-LAMB2突变诱导的足细胞内质网应激激活的生存通路,以确定
足细胞内质网应激在携带有害错义突变的NS患者中的作用
研究遗传型NS的新治疗策略。为了实现我们的研究目标,我们将利用
小鼠遗传模型和Access两大人类NS队列,肾病综合征研究网络
(海王星)和华盛顿大学肾脏翻译研究核心(Wu KTRC)。我们有
组建了一个跨学科团队,其中包括多名合作调查员和合作者,他们需要
具有开创性的内质网应激研究、人类和小鼠遗传学、下一代测序和高级
吞吐量筛选。
拟议的研究将帮助我们根据潜在的分子机制对NS患者进行分类,分层
疾病风险,并为足细胞内质网功能障碍引起的NS患者发现高度针对性的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ying Maggie Chen其他文献
Beyond Redox Regulation: Novel Roles of TXNIP in the Pathogenesis and Therapeutic Targeting of Kidney Disease
超越氧化还原调节:硫氧还蛋白相互作用蛋白在肾脏疾病发病机制及治疗靶点中的新作用
- DOI:
10.1016/j.ajpath.2024.12.011 - 发表时间:
2025-04-01 - 期刊:
- 影响因子:3.600
- 作者:
Chuang Li;Yili Fang;Ying Maggie Chen - 通讯作者:
Ying Maggie Chen
Ying Maggie Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ying Maggie Chen', 18)}}的其他基金
Ultrabright Plasmonic-Fluor Nanosensor-Enabled Noninvasive Management of Pediatric Nephrotic Syndrome
超亮等离子体荧光纳米传感器支持小儿肾病综合征的无创治疗
- 批准号:
10593497 - 财政年份:2022
- 资助金额:
$ 30.5万 - 项目类别:
PODOCYTE ENDOPLASMIC RETICULUM STRESS AND NEPHROTIC SYNDROME
足细胞内质网应激与肾病综合征
- 批准号:
10161772 - 财政年份:2017
- 资助金额:
$ 30.5万 - 项目类别:
PHARMACOLOGICAL RESCUE OF MUTANT LAMININ IN NEPHROTIC SYNDROME
突变层粘连蛋白对肾病综合征的药理学拯救
- 批准号:
8953410 - 财政年份:2015
- 资助金额:
$ 30.5万 - 项目类别:
PHARMACOLOGICAL RESCUE OF MUTANT LAMININ IN NEPHROTIC SYNDROME
突变层粘连蛋白对肾病综合征的药理学拯救
- 批准号:
9110975 - 财政年份:2015
- 资助金额:
$ 30.5万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 30.5万 - 项目类别: